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Short hairpin RNAs targeting 66 Rho-GEFs were screened for inhibition of chemotaxis. Six Rho-GEFs
(p63RhoGEF, Trio, Duet, Net1, Frabin/Fgd4, and AAH33666) were found to be required for the serum-
induced chemotactic migration of MDA-MB-231 human breast carcinoma cells. Knockdown of
p63RhoGEF suppressed serum-induced RhoA activation and chemotaxis and caused the aberrant
formation of multiple lamellipodial protrusions after serum stimulation while control cells formed
a single polarized lamellipodium. These results indicate that p63RhoGEF plays a crucial role in
serum-induced chemotaxis by limiting lamellipodial protrusion to one direction via RhoA
activation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Chemotactic cell migration is essential for numerous physiolog-
ical and pathological processes, including embryogenesis, organo-
genesis, immune responses, and tumor invasion and metastasis.
The Rho family of small GTPases, including RhoA, Rac1, and
Cdc42, are key regulators of actin cytoskeletal reorganization and
play crucial roles in cell migration [1]. They are activated by Rho
guanine nucleotide exchange factors (Rho-GEFs), which catalyze
the conversion of Rho GTPases from the inactive GDP-bound form
to the active GTP-bound form. In the human genome, there are
approximately 70 Dbl-like Rho-GEF genes [2,3]. These Rho-GEFs
contain a catalytic Dbl homology (DH) domain that is usually
followed by a pleckstrin homology (PH) domain, but the regions
outside the DH–PH domains are not conserved [2,3]. The large
number of Rho-GEFs, compared with the small number (approxi-
mately 20) of Rho family GTPases, raises the possibility that each
Rho-GEF selectively regulates speciﬁc functions of target Rho fam-
ily GTPases. Thus, it is important to determine the functional rolesand regulation mechanisms of each Rho-GEF in the context of var-
ious cellular processes.
p63RhoGEF was originally identiﬁed as a 63 kDa Rho-GEF that
speciﬁcally activates RhoA [4]. An N-terminally truncated variant
of p63RhoGEF, termed GEFT, was then identiﬁed and reported to
activate Rac1 and Cdc42 [5], but later studies argued that GEFT also
activates RhoA [6–9]. Several lines of evidence indicate that
p63RhoGEF directly binds to the activated Gaq/11, but not Ga12/13,
subunits of heterotrimeric G proteins and thereby functions down-
stream of Gaq/11 to mediate the signaling pathways linking Gaq/11-
coupled receptors to RhoA activation [7–9]. Biochemical and
crystallographic studies revealed that Gaq activates p63RhoGEF
by relieving the autoinhibition of the catalytic DH domain by
the PH domain [7–9]. Although the crucial role of p63RhoGEF in
cellular responses induced by agonists of Gaq/11-coupled receptors,
such as angiotensin II- or endothelin-1-induced contraction of
vascular smooth muscle cells, has become evident [10,11], little
is known about its functional role in cell migration.
This study aimed to identify Rho-GEFs involved in serum-in-
duced chemotactic migration in MDA-MB-231 human breast carci-
noma cells. A screen of short hairpin RNAs (shRNAs) targeting 66
Rho-GEFs revealed that at least six Rho-GEFs (including p63RhoG-
EF) are required for the chemotactic response of MDA-MB-231
cells. The results also provide evidence that p63RhoGEF is involved
in forming the single polarized lamellipodium in response to ser-
um stimulation.
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2.1. Cell culture and transfection
MDA-MB-231 cells were cultured in Dulbecco’s modiﬁed Ea-
gle’s medium/Ham’s F12medium supplemented with 10% fetal calf
serum (FCS). Cells were transfected with plasmids using Lipofect-
amine LTX (Invitrogen).
2.2. Plasmid construction
Expression plasmids encoding Rho(T19 N), Rac1(T17 N), and
Cdc42(T17 N) were provided by K. Kaibuchi (Nagoya University). To
construct the plasmid encoding YFP-p63RhoGEF, the cDNA for
p63RhoGEF was ampliﬁed by PCR and inserted into the pEYFP-C1 vec-
tor (Clontech). The plasmid for GEF-inactive p63RhoGEF(L301E) [4]
was constructed using a site-directed mutagenesis kit (Stratagene).
2.3. Construction of a Rho-GEF shRNA library
To construct a shRNA library targeting each of the human Rho-
GEFs, candidate 19-nucleotide shRNA sequences were designed
according to the reported method [12] and inserted into the pSU-
PER vector (Oligoengine). To assess knockdown, each shRNA plas-
mid was transfected into Jurkat cells together with the pNUL
reporter plasmid, which encodes a chimeric cDNA composed of
luciferase and the cDNA fragment (400 base pairs) of the target
gene, as reported [13]. If a shRNA construct effectively suppresses
the expression of its target gene, luciferase expression will be re-
duced. Thus, the silencing effect of each shRNA was monitored
by measuring luciferase activity. Using this reporter assay, one or
two effective shRNA constructs targeting each of the 66 human
Rho-GEFs were obtained (Supplementary Table S1). As a control
shRNA, GL2 (50-CCGTACGCGGAATACTTCGA-30) or mutated SSH1
shRNA (50-TCTTCCCCCAAGAAAGATA-30) was used.
2.4. Cell migration assays
To screen Rho-GEF shRNAs for their effect on cell migration,
MDA-MB-231 cells were cotransfected with a YFP plasmid and a
Rho-GEF shRNA plasmid (with a molar ratio of 1:5) and cultured
for 48 h. Cells were serum-starved for 3 h, suspended in serum-free
medium, and then aliquots of 4  104 cells were loaded into the
upper well of Transwell chambers (8 lm pore size, Corning). The
lower wells were ﬁlled with DMEM/Ham’s F12 medium, with or
without 10% FCS. For chemokinetic migration assays, 10% FCS
was added to both the upper and lower wells. After incubation
for 4–8 h, cells were ﬁxed with 4% formaldehyde and stained with
40,6-diamidino-2-phenylindole. After the total number of cells was
counted, the non-migrating cells on the top of the membrane were
gently removed by wiping and rinsing, and the number of migrat-
ing cells on the lower face of the membrane was counted. The
motility index was calculated as the percentage of migrating cells
from the total number of cells.
2.5. Reverse transcription (RT)-PCR
To analyze the expression of Rho-GEF mRNAs, total RNA was
isolated from MDA-MB-231 cells using the RNeasy Mini Kit (Qia-
gen) and reverse-transcribed to yield single-stranded cDNAs using
the SuperScript Choice System (Invitrogen). The cDNAs were sub-
jected to PCR ampliﬁcation, as described [13]. The speciﬁc primers
used for amplifying p63RhoGEF and GEFT cDNAs were 50-GAATCC-
TATTCCATTGCGGG-30 (p63RhoGEF-sense), 50-GGGGTGCCCTGGTG
AAAT-30 (GEFT-sense), and 50-TCTCCTCAGGCCACTGAC-30 (p63RhoGEF/GEFT-antisense) [6]. The MegaMan Human Transcriptome Li-
brary (Agilent Technologies) was used as a control template to de-
tect both transcripts.
2.6. Active RhoA and Rho-GEF pull-down assays
The active form of RhoAwas analyzed by pull-down assays using
the Rho-binding domain (RBD) of rhotekin fused to glutathione-S-
transferase (GST), as described [14]. The active form of p63RhoGEF
was analyzed by pull-down assays using RhoA(G17A), a guanine
nucleotide-free form of RhoA, fused to GST, as described [15].
2.7. Immunoblotting
Cell lysates were subjected to immunoblotting as described pre-
viously [13]. Rabbit polyclonal antibodies against p63RhoGEF/GEFT
(14839-1-AP; Proteintech) and GFP (A6455; Molecular Probes),
and mouse monoclonal antibodies against RhoA (sc-418; Santa
Cruz) and a-tubulin (B-5-1-2; Sigma–Aldrich) were purchased
commercially.
2.8. Cell staining
Cells were ﬁxed with 4% formaldehyde in phosphate-buffered
saline (PBS) for 20 min and permeabilized with PBS containing
0.1% Triton X-100. After washing with PBS, cells were stained with
Alexa568-phalloidin (Molecular probes) to detect F-actin. Fluores-
cence images were obtained using a ﬂuorescence microscope
(DMIRBE, Leica).3. Results
3.1. Identiﬁcation of Rho-GEFs involved in the chemotactic migration
of MDA-MB-231 cells
To identify Rho-GEFs involved in serum-induced tumor cell
migration, Rho-GEF shRNAs were screened for suppression of ser-
um-induced chemotactic migration in MDA-MB-231 breast carci-
noma cells. Prior to the screening, the effect of expressing
dominant-negative mutants of RhoA, Rac1, or Cdc42 on MDA-
MB-231 cell chemotaxis was assessed. Chemotactic migration
was analyzed using Transwell chambers where serum was added
only to the lower chamber. Transfection of RhoA(T19N),
Rac1(T17N), or Cdc42(T17N) signiﬁcantly suppressed the serum-
induced chemotactic migration of MDA-MB-231 cells (Fig. 1A),
indicating that RhoA, Rac1 and Cdc42 are crucial for the serum-in-
duced chemotactic response.
The effect of knocking down each Rho-GEF was then examined.
Two independent shRNA plasmids targeting each of the 66 human
Rho-GEFs were constructed, and silencing of target expression was
assessed by luciferase reporter assays, as reported previously [13].
MDA-MB-231 cells were transfected with each Rho-GEF shRNA
plasmid, cultured for 48 h, serum-starved for 3 h, and then sub-
jected to chemotaxis assay. Of all the shRNA pairs targeting the
66 Rho-GEFs, six pairs, each targeting the Rho-GEF AAH33666,
Duet, Frabin/FGD4, Net1, p63RhoGEF, or Trio, showed signiﬁcant
suppression of chemotaxis with each of the two shRNAs, while four
pairs, targeting Rho-GEF FGD1, P-REX2, Tiam2, or a-Pix, showed
signiﬁcant suppression of chemotaxis with only one of the two
shRNAs (Fig. 1B, Supplementary Table S2). RT-PCR analysis re-
vealed that transcripts of the former six Rho-GEFs are expressed
in MDA-MB-231 cells (Fig. 1C). These results suggest that at least
these six Rho-GEFs (AAH33666, Duet, Frabin/FGD4, Net1,
p63RhoGEF, and Trio) are involved in the serum-induced chemo-
tactic migration of MDA-MB-231 cells. This study focused on the
Fig. 1. Screening of Rho-GEFs involved in serum-induced chemotaxis. (A) Effect of RhoA(T19 N), Rac1(T17 N), and Cdc42(T17 N) on chemotaxis. MDA-MB-231 cells were
transfected with plasmids, cultured for 24 h, serum-starved for 3 h, and subjected to chemotactic migration assays. (B) Effect of Rho-GEF shRNAs on chemotaxis. MDA-MB-
231 cells were transfected with shRNA plasmids, cultured for 48 h, serum-starved for 3 h, and subjected to chemotaxis assays. In (A) and (B), data represent the means ± S.D.
of three independent experiments, with the motility in serum-stimulated control cells set as 100%. ⁄, P < 0.01. (C) Expression of Rho-GEF mRNAs in MDA-MB-231 cells. Total
RNA from MDA-MB-231 cells was subjected to RT-PCR using speciﬁc primers designed to amplify PCR products of 400 base pairs [13]. (D) Expression of p63RhoGEF and
GEFT mRNA in MDA-MB-231 cells. RT-PCR analysis was performed as described previously [6]. A MegaMan Human Transcriptome Library was used as a control template.
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formation (see Fig. 5). p63RhoGEF has an N-terminally truncated
isoform, termed GEFT [5,6]. RT-PCR analysis using speciﬁc primers
for each isoform revealed that p63RhoGEF, but not GEFT, is ex-
pressed in MDA-MB-231 cells (Fig. 1D).
3.2. p63RhoGEF is involved in serum-induced RhoA activation
The role of p63RhoGEF in serum-induced RhoA activation was
examined. Measurement of activated RhoA by GST-RBD pull-down
assays revealed that serum stimulation induced RhoA activation
and that ectopic expression of p63RhoGEF increased the levels of
active RhoA in both serum-stimulated and unstimulated MDA-
MB-231 cells (Fig. 2A). In contrast, expression of p63RhoG-
EF(L301E), a GEF-inactive mutant [4], suppressed serum-induced
RhoA activation (Fig. 2A). These results indicate that p63RhoGEF
catalyzes RhoA activation, as reported [4,6], and that p63RhoG-
EF(L301E) acts as a dominant-negative form. The effect of
p63RhoGEF knockdown on serum-induced RhoA activation was
then examined. Transfection of p63RhoGEF shRNA suppressed
the expression of endogenous p63RhoGEF protein (Fig. 2B). GST–RBD pull-down assays revealed that knockdown of p63RhoGEF
by shRNA signiﬁcantly suppressed serum-induced RhoA activation
in MDA-MB-231 cells (Fig. 2C). Similar results were obtained when
we used another shRNA targeting p63RhoGEF (Supplementary
Fig. S1A and B). These results indicate that p63RhoGEF is crucially
involved in serum-induced RhoA activation. The serum-induced
changes in the activity of endogenous p63RhoGEF was examined
by pull-down assays using GST–RhoA(G17A), a guanine nucleo-
tide-free form of RhoA known to bind speciﬁcally to the active
form of Rho-GEFs [15]. The level of active p63RhoGEF increased
10 to 60 min after serum stimulation (Fig. 2D). These results indi-
cate that p63RhoGEF is activated by serum and is involved in ser-
um-induced RhoA activation in MDA-MB-231 cells.
3.3. Effect of p63RhoGEF overexpression on actin organization and cell
morphology
The effect of p63RhoGEF overexpression on actin organization
and cell morphology was then examined. MDA-MB-231 cells were
transfected with YFP or YFP-p63RhoGEF, and stained with
Alexa568-phalloidin to detect F-actin. Control YFP-expressing cells
Fig. 2. p63RhoGEF is involved in serum-induced RhoA activation. (A) Effects of expression of p63RhoGEF (WT or L301E) on RhoA activity. MDA-MB-231 cells were transfected
with YFP or YFP-p63RhoGEF (WT or L301E), cultured for 24 h, serum-starved for 3 h, and exposed to 10% FCS for 20 min. RhoA activity was measured by GST-RBD pull-down
assays. Relative RhoA activity is shown as the mean ± S.D. of three independent experiments, with the activity in control cells in the absence of FCS set as 1.0. (B) Effect of
p63RhoGEF shRNA on p63RhoGEF expression. MDA-MB-231 cells were transfected with control or p63RhoGEF shRNA #1, and cultured for 48 h. Cell lysates were
immunoblotted with anti-p63RhoGEF antibody. (C) p63RhoGEF knockdown suppresses serum-induced RhoA activation. MDA-MB-231 cells were transfected with shRNA,
cultured for 48 h, and analyzed as in (A). (D) Time course of p63RhoGEF activity. MDA-MB-231 cells were cultured for 24 h, serum-starved for 3 h and exposed to 10% FCS for
the times indicated. The Rho-GEF activity of endogenous p63RhoGEF was measured by pull-down assays using GST-RhoA(G17A). Relative Rho-GEF activity is shown as the
mean ± S.D. of three independent experiments, with the activity before FCS exposure set as 1.0. ⁄, P < 0.001; **, P < 0.01; ⁄⁄⁄, P < 0.05.
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but displayed a polarized cell morphologywith a single F-actin-rich
lamellipodial protrusion on one side of the cell after serum stimula-tion (Fig. 3A). Compared with control YFP, expression of YFP-
p63RhoGEF often induced cell rounding and the formation of actin
stress ﬁbers both before and after serum stimulation (Fig. 3B). These
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with the diffuse distribution of control YFP, YFP-p63RhoGEF was
localized on the plasmamembrane, as reported [16] (Fig. 3A and B).
3.4. Effect of p63RhoGEF knockdown on serum-induced chemotaxis
and chemokinesis
To examine the role of p63RhoGEF in serum-induced cell migra-
tion further, the effect of p63RhoGEF knockdown on directional
(chemotactic) and random (chemokinetic) migration was analyzed
in MDA-MB-231 cells in response to serum stimulation. Serumwas
added only to the lower chamber for chemotaxis assays, whereas it
was added to both the lower and upper chambers for chemokinesisFig. 3. Effect of p63RhoGEF expression on cell morphology and F-actin organization. MD
were cultured for 24 h, serum-starved for 3 h, and stimulated with 10% FCS for 20 min
phalloidin to detect F-actin. Scale bar, 20 lm.assays. Knockdown of p63RhoGEF signiﬁcantly suppressed the
chemotactic migration of MDA-MB-231 cells toward serum; by
contrast, knockdown of p63RhoGEF had no signiﬁcant effect on
the chemokinetic response of cells (Fig. 4; Supplementary
Fig. S1C). These results suggest that p63RhoGEF plays a more spe-
ciﬁc role in chemotactic migration than chemokinetic migration.
3.5. p63RhoGEF is involved in the formation of the single polarized
lamellipodium
To elucidate the mechanism by which p63RhoGEF knockdown
impairs serum-induced chemotactic migration, the effect of
p63RhoGEF knockdown on serum-induced changes in cellA-MB-231 cells were transfected with control YFP (A) or YFP-p63RhoGEF (B). Cells
(+ FCS) or left unstimulated ( FCS). Cells were ﬁxed and stained with Alexa568-
Fig. 4. Effect of p63RhoGEF knockdown on chemotaxis and chemokinesis. MDA-
MB-231 cells were transfected with shRNAs, cultured for 48 h, serum-starved for
3 h, and subjected to chemotactic and chemokinetic migration assays. Data
represent the means ± S.D. of three independent experiments, with the chemotactic
migration of control cells set as 100%. ⁄⁄, P < 0.01; N.S., not signiﬁcant.
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cells were cotransfected with YFP and control shRNA or p63RhoG-
EF shRNA, and cell morphology and F-actin organization were ana-
lyzed by YFP ﬂuorescence and Alexa568-phalloidin staining. As
described above, control cells displayed a polarized cell morphol-
ogy with a single lamellipodium after serum stimulation
(Fig. 5A). This polarized cell morphology and single lamellipodium
formation appear to support directional cell migration. Knockdown
of p63RhoGEF had no apparent effect on the overall cell shape and
F-actin organization before serum stimulation, but caused the pro-
duction of multiple lamellipodial protrusions around the cell
periphery after serum stimulation (Fig. 5A). Quantitative analysis
showed that 36% and 11% of control shRNA cells displayed single
and multiple lamellipodial protrusion(s), respectively, after serum
stimulation. By contrast, 17% and 32% of p63RhoGEF shRNA cells
displayed single and multiple lamellipodial protrusion(s), respec-
tively, after serum stimulation (Fig. 5A). Similar results were ob-
tained when we used another shRNA targeting p63RhoGEF
(Supplementary Fig. S1D).
To examine the role of p63RhoGEF in polarized lamellipodium
formation further, the effect of p63RhoGEF(L301E), a GEF-inactive
p63RhoGEF mutant [4], was analyzed. Similar to the phenotype of
p63RhoGEF knockdown, overexpression of p63RhoGEF(L301E) de-
creased the number of cells with single lamellipodium and in-
creased the number of cells with multiple lamellipodia after
serum stimulation (Fig. 5B and C). Taken together, these results
suggest that p63RhoGEF plays a crucial role in serum-induced che-
motactic migration by facilitating the formation of the single polar-
ized lamellipodial protrusion in response to serum stimulation.
We also analyzed the effects of knockdown of the other ﬁve
Rho-GEFs, identiﬁed in the screen, on serum-induced polarized
lamellipodium formation. Duet and Trio shRNAs signiﬁcantly de-
creased the number of cells with single lamellipodium and Duet
shRNA increased the number of cells with multiple lamellipodia,compared with control shRNA, although their effects were weaker
than those of p63RhoGEF shRNA (Fig. 5D). In contrast, knockdown
of AAH33666, Frabin/Fgd4 or Net1 had no apparent effect on polar-
ized lamellipodium formation. These results indicate that
p63RhoGEF, Duet and Trio play a speciﬁc role in regulating ser-
um-induced polarized lamellipodium formation.4. Discussion
Using a shRNA library targeting 66 Rho-GEFs, six Rho-GEFs
were found to be involved in serum-induced chemotaxis in
MDA-MB-231 cells. Reﬂecting the essential role of RhoA, Rac1,
and Cdc42 in chemotactic migration, the six Rho-GEFs identiﬁed
in this study have distinct target speciﬁcity: p63RhoGEF, Net1,
Duet (containing the C-terminal DH–PH domain of Kalirin), and
the C-terminal DH–PH domain of Trio (Trio-C) activate RhoA, Fra-
bin/FGD4 activates Cdc42, and the N-terminal DH–PH domain of
Trio (Trio-N) activates Rac1 and RhoG [2,3,9,17,18]. The target of
AAH33666 remains unknown. Trio and Net1 were reported to be
involved in cell migration [17,19], but the roles of other Rho-GEFs
in cell migration have yet to be elucidated. These six Rho-GEFs ap-
pear to play crucial roles in the chemotactic response to serum by
coordinately regulating the activity of their respective target Rho
family GTPases. Further studies on the signaling pathways and spa-
tiotemporal regulation of each Rho-GEF activity will clarify the
functional roles of individual Rho-GEFs and the mechanism of their
coordination in chemotactic cell migration.
Of about 70 Rho-GEFs, the DH–PH domain of p63RhoGEF is
most closely related to those of Trio-C and Duet [2,3]. All of these
Rho-GEFs are activated by Gaq binding to the conserved C-terminal
extensions of their PH domains [8,9]. Thus, they constitute a sub-
family of Rho-GEFs that function as the Gaq/11 effectors, which
mediate RhoA activation downstream of Gaq/11-coupled receptors.
Intriguingly, all three Rho-GEFs were identiﬁed in our screen and
knockdown of these Rho-GEFs affected polarized lamellipodium
formation, suggesting that the signaling pathway of Gaq/11-cou-
pled receptor-mediated RhoA activation plays a pivotal role in
the serum-induced chemotaxis and polarized lamellipodium for-
mation of MDA-MB-231 cells. This hypothesis will be validated
after identiﬁcation of the agonist(s) in serum that induces the che-
motactic response, and of their receptors.
Knockdown of p63RhoGEF suppressed cell migration, indicating
that p63RhoGEF promotes cell migration. By contrast, prevention
of Gaq-mediated p63RhoGEF activation by MLK3 was reported to
be required for cell migration [20]. These apparently contradictory
results suggest that p63RhoGEF is indispensable for cell migration
but its hyperactivation also impedes cell migration. Indeed, over-
expression of p63RhoGEF or active RhoA(G14V) suppressed ser-
um-induced chemotaxis (data not shown). Thus, it is likely that
proper control of the levels of p63RhoGEF and RhoA activation is
necessary for chemotactic migration.
RhoA is required for cell migration by generating contractile
forces through ROCK-mediated myosin light chain activation [1].
In addition, previous studies showed that inhibition of RhoA sig-
naling produces multiple competing lamellipodial protrusions that
disrupt productive migration, indicating that RhoA signaling con-
tributes to cell migration by suppressing inappropriate lamellipo-
dial protrusions away from the leading edge [21,22]. Whereas
Rac signaling promotes lamellipodium formation, RhoA signaling
negatively regulates Rac activity [23]. Thus, inhibition of RhoA sig-
naling may produce multiple lamellipodia through upregulation of
Rac signaling. Our results showed that knockdown of p63RhoGEF
or overexpression of GEF-inactive p63RhoGEF(L301E) induces mul-
tiple lamellipodia around the cell periphery after serum stimula-
tion, suggesting that serum-induced p63RhoGEF activation plays
Fig. 5. p63RhoGEF is required for the formation of a single polarized lamellipodium. (A) Effect of p63RhoGEF knockdown on polarized lamellipodium formation. MDA-MB-
231 cells were cotransfected with YFP and control or p63RhoGEF shRNA. Cells were cultured for 48 h, serum-starved for 3 h, and stimulated with 10% FCS for 20 min (+FCS) or
left unstimulated (FCS). Cells were ﬁxed and stained with Alexa568-phalloidin. Right panel shows quantitative data. Cells treated with FCS were classiﬁed into three
categories; cells with single lamellipodium (white bar), multiple lamellipodia (black bar), and no lamellipodium (not shown). (B) Effect of expression of p63RhoGEF(L301E) on
polarized lamellipodium formation. Cells were transfected with YFP or YFP-p63RhoGEF(L301E) and analyzed as in (A). In (A) and (B), arrows indicate the positions of
lamellipodial protrusions. Scale bar, 20 lm. (C) Immunoblot analysis of expression of YFP-p63RhoGEF(L301E). (D) Effects of knockdown of the other ﬁve Rho-GEFs on
polarized lamellipodium formation. MDA-MB-231 cells were transfected with the indicated Rho-GEF shRNA and analyzed after serum stimulation, as in (A). Data represent
the means ± S.D. of three independent experiments. ⁄, P < 0.001; ⁄⁄⁄, P < 0.05.
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the lamellipodium to the direction of cell movement and maintain-
ing it at the leading edge.
The crucial role of RhoA in tumor cell migration and invasion
has been well established [24,25], but it is difﬁcult to target that
speciﬁc function of RhoA. Identiﬁcation of p63RhoGEF and related
Gaq/11-coupled Rho-GEFs as the essential RhoA activators for tu-
mor cell migration provides potential therapeutic targets for sup-
pressing RhoA-mediated tumor cell invasion and metastasis.
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